Latest News & Features
Americas
Hedge fund manger Kyle Bass has secured his first inter partes review trial after the Patent Trial and Appeal Board instituted a challenge against a patent owned by biopharmaceutical company Shire. 9 October 2015
Americas
A US resident has been charged with trafficking counterfeit erectile dysfunction pills, the government has revealed. 8 October 2015
Big Pharma
The CJEU’s decision on how an SPC term is to be determined is likely to be welcomed by applicants and owners, but the court has left them to work out how to apply the ruling, say Natalia Wegner-Cribbs and Daniel Wise of Carpmaels & Ransford. 8 October 2015
Asia-Pacific
Australia’s highest court has said that naturally occurring nucleic acid molecules are not patentable, overturning a lower court ruling. 7 October 2015
Asia-Pacific
Australia’s government has said the period of data exclusivity available for biological drugs in the Trans-Pacific Partnership will be five years, despite pressure from the US to extend it to 12. 7 October 2015
Europe
The Court of Justice of the European Union (CJEU) has ended the uncertainty over the term of supplementary protection certificates (SPCs) by ruling that they begin once a party is notified of a marketing authorisation for a drug. 6 October 2015
Americas
The US Supreme Court has declined to hear manufacturer W L Gore & Associates’s request for clarity on whether US patent law stipulates that patent licensing agreements must be placed in writing. 6 October 2015
Americas
The US Court of Appeals for the Federal Circuit has upheld a lower court’s ruling that Spectrum Pharmaceuticals’s Fusilev patent is invalid and wasn’t infringed by generics company Sandoz. 5 October 2015
Americas
Law firm Goodwin Procter has promoted five lawyers to partner in the firm’s intellectual property practice, including two life sciences specialists. 5 October 2015
Americas
The US Federal Trade Commission has intervened in a ‘product hopping’ dispute concerning an acne treatment drug. 2 October 2015